| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | 17ERJ0MKGI |
| InChI Key | PYNXFZCZUAOOQC-UTKZUKDTSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H29NO5 |
| Molecular Weight | 411.5 |
| AlogP | 3.84 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 11.0 |
| Polar Surface Area | 92.7 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Neprilysin inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 23.12 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -22.5--0.92 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypertension | 3 | D006973 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Chagas Cardiomyopathy | 3 | D002598 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| ST Elevation Myocardial Infarction | 3 | D000072657 | ClinicalTrials |
| Hypertension, Pulmonary | 3 | D006976 | ClinicalTrials |
| Cardiomyopathy, Hypertrophic | 2 | D002312 | ClinicalTrials |
| Aortic Valve Insufficiency | 2 | D001022 | ClinicalTrials |
| Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
| Essential Hypertension | 2 | D000075222 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 1 | D045169 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 149709-62-6 |
| ChEBI | 134714 |
| ChEMBL | CHEMBL3137301 |
| DrugBank | DB09292 |
| DrugCentral | 5012 |
| EPA CompTox | DTXSID20164370 |
| FDA SRS | 17ERJ0MKGI |
| Guide to Pharmacology | 7857 |
| PubChem | 9811834 |
| SureChEMBL | SCHEMBL2707112 |
| ZINC | ZINC000003792417 |